d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] Phase I dose escalation of anti-PlGF combined with bevacizumab 10 mg/kg every 2 weeks in recurrent GBM [Country] DK [Cancer type] 
Glioblastoma
Nordic NECT - Inclusion completed
Cancer type